(Reuters) -Novocure Ltd's experimental device to treat a type of lung cancer helped in extending overall survival among patients in a late-stage study, but concerns around its commercial success sent ...
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
New assay provides rapid access to guideline recommended biomarkers within days of a non-small cell lung cancer diagnosis. CAMBRIDGE, England and RESEARCH TRIANGLE PARK, N.C., Sept. 5, 2023 ...
The Mid-South, for multiple reasons, is considered an epicenter for myriad health issues — heart disease, diabetes, stroke, obesity and more. It's also considered the epicenter for lung cancer, and as ...
CARLSBAD, Calif., July 11, 2023 /PRNewswire/ -- ChromaCode, Inc., a genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients and physicians, ...
In a recent study published in the Radiology, researchers performed a single-center, open-label randomized controlled trial (RCT) to investigate whether commercial artificial intelligence (AI)-debased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback